NasdaqGS:SENSMedical Equipment
Senseonics Holdings (SENS) Is Up 27.7% After Q3 Revenue Surge and Record New Patient Growth Has the Bull Case Changed?
On October 6, 2025, Senseonics Holdings announced preliminary unaudited revenue for the third quarter ended September 30, reporting approximately US$8.1 million, an increase of 91% over the same period in 2024, primarily attributed to roughly 160% new patient growth in the U.S.
This upturn in both revenue and new patient adoption highlights more robust market traction, suggesting a potential acceleration in demand for the company’s continuous glucose monitoring systems.
We’ll now explore how...